Thailand Cancer Immunotherapy Market Analysis

Thailand Cancer Immunotherapy Market Analysis

$ 3999

Thailand's cancer immunotherapy market is expected to witness growth from $135 Mn in 2022 to $240 Mn in 2030 with a CAGR of 7.4% for the forecasted year 2022-30. The increasing incidence of cancer and the improvements in healthcare spending in Thailand are responsible for the growth of the market. The Thailand cancer immunotherapy market is segmented by type, application, and end user. Silom Medical, Emergpharma, and Bayer are the major players in the Thailand cancer immunotherapy market.

ID: IN10THPH032 CATEGORY: Pharmaceuticals GEOGRAPHY: Thailand AUTHOR: Dr. Parul Choudhary

Buy Now

Thailand Cancer Immunotherapy Market Executive Analysis

Thailand's cancer immunotherapy market is expected to witness growth from $135 Mn in 2022 to $240 Mn in 2030 with a CAGR of 7.4% for the forecasted year 2022-30. The Universal Coverage Scheme would receive $6 Bn in the fiscal year 2023, an increase of 4.12% from the prior year, as agreed by the Thai cabinet. The recently introduced services are mostly associated with COVID-19, including costs for RT-PCR tests, antigen test kits (ATKs), and services for COVID-19 immunization.

With an age-adjusted mortality rate of 89.7 per 100 000 for males and 67.2 per 100 000 for females in Khon Kaen 133.3 for males and 121.0 for females in Chiang Mai, cancer has been the top cause of death in Thailand. Immunotherapy is a kind of cancer treatment that strengthens the body's inbuilt defences against cancer. It aids in the immune system's ability to identify cancer cells and fortify its reactions, enabling the immune system to kill the cancer cells. Checkpoint inhibitors are a type of immunotherapy used to treat cancer, including nivolumab and pembrolizumab. They suppress the signal that would have stopped white blood cells with activated T-cell receptors from attacking cancer cells. The US and Thai FDAs have both approved both medications. Compared to chemotherapy, both medications have been demonstrated to slow the advancement of the disease and improve the survival rate of cancer patients.  Additionally, compared to chemotherapy, radiation therapy has fewer adverse effects like bone marrow suppression, nausea, and vomiting. As a result, they are frequently employed as cancer treatments in several nations.

Thailand Cancer Immunotherapy Market Analysis

Market Dynamics

Market Growth Drivers

With a high incidence rate and an increasing number of cases each year, cancer is a significant public health concern in Thailand. As a result, effective cancer therapies like immunotherapy are in more demand. The Thai government has been aggressively pushing for the growth of the biopharmaceutical sector and has unveiled a number of programs to aid in the expansion of the Thailand cancer immunotherapy market. Thailand has been spending more on healthcare recently, and this trend is anticipated to continue. Increased funding for cancer therapies, particularly immunotherapy, is likely to arise from this. The creation of more effective and targeted immunotherapies is now possible because of technological developments like next-generation sequencing and personalized medicine, which are predicted to accelerate Thailand's cancer immunotherapy market growth.

Market Restraints

Cancer immunotherapy can be expensive, and this expense could be a major obstacle to its acceptance in Thailand, especially given the country's healthcare system, which relies heavily on patients paying out of pocket. This may reduce the market's ability to expand. Many patients may find it difficult to get immunotherapy because the Thai government's reimbursement procedures are still comparatively lax, especially for those who cannot afford to pay out of pocket. Although immunotherapy is becoming more well-known and accepted in Thailand, some patients and medical professionals might still be dubious about its efficacy, which could limit demand and adoption thereby limiting the expansion of the Thailand cancer immunotherapy market.

Competitive Landscape

Key Players

  • VE Healthcare Group (THA)
  • OLIC (THA)
  • Pacific Healthcare Group (THA)
  • Silom Medical (THA)
  • Emergpharma (THA)
  • Bayer
  • AstraZeneca
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Pfizer
  • Eli Lily
  • Novartis

Healthcare Policies and Regulatory Landscape

The National Health Security Office (NHSO) and the Universal Coverage Scheme (UCS) are in charge of overseeing the healthcare system's insurance plans and payment procedures for cancer therapies like immunotherapy in Thailand. The bulk of the populace is covered by the UCS, a public health insurance program, which includes cancer sufferers. It makes a variety of cancer treatments, such as chemotherapy, radiation therapy, and surgery, accessible. Immunotherapy coverage, however, may have restrictions, and some patients may be required to pay out of cash for these therapies. The NHSO is in charge of managing the government's healthcare budget and approving payments for cancer treatments. The Thai Food and Drug Administration (FDA) must approve a cancer treatment before it can be paid for. It must also meet specific requirements, such as being clinically effective, secure, and economical. The NHSO and the UCS often fund immunotherapy treatments, but coverage may change based on the precise immunotherapy regimen and the patient's unique situation. Patients could have to cover some of the expense of immunotherapy out-of-pocket, and some immunotherapy therapies would need prior NHSO approval before they can be reimbursed.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cancer Immunotherapy Segmentation

By Type (Revenue, USD Billion):

  • Monoclonal Antibodies
  • Cancer Vaccines
  • Checkpoint Inhibitors
  • Immunomodulators
  • PD-1/PD-L1
  • CTLA-4

By Application (Revenue, USD Billion):

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Melanoma
  • Others

By End User (Revenue, USD Billion):

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Cancer Research Centers

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

Silom Medical, Emergpharma, and Bayer are the major players in the Thailand cancer immunotherapy market.

The Thailand cancer immunotherapy market is expected to grow from $135 Mn in 2022 to $240 Mn in 2030 with a CAGR of 7.4% for the forecasted year 2022-2030.

The Thailand cancer immunotherapy market is segmented by type, application, and end user.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 09 February 2024
Updated by: Ritu Baliya

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter